НовостиBenzingaWells Fargo Maintains Overweight on Septerna, Raises Price Target to $61 Wells Fargo Maintains Overweight on Septerna, Raises Price Target to $61 Benzinga 2026.11.04 15:34 (GMT+0) Открыть на Benzinga Другие новости